Taken together, these data suggest that Ang II-induced cardiac hypertrophy and hypertension are dependent on the presence of NADPH oxidase, increased oxidative stress, and activation of NF-κB, and require concomitant generation of TNF-α. Here, FMO5 is linked to cardiac hypertrophy.